The hefty tariffs President-elect Trump has pledged to levy on U.S. imports could impact the price and availability of pharmaceutical drugs. Trump has floated 25 percent tariffs on imports from ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022. The over 250 drug hikes represent an increase from ...

This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...

Seeking to one day return to Nagi’s side, Reo developed a killer technique (weapon) for himself—the Chameleon. Just like it sounds, Reo's abilities make him capable of replicating various ...

Business development certainly has a role to play in companies’ innovation strategies, too, with 77% of executives surveyed noting they expect M&A to increase in 2025. AI's growing impact Beyond ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) Senores Pharmaceuticals IPO closes ...

Pharma department has reprimanded AbbVie Healthcare for sending 30 doctors to Paris and Monaco, spending over Rs 1.9 crore, violating uniform travel and hospitality guidelines. The National ...

Although Recursion Pharmaceuticals offers compelling possibilities, I believe that without better visibility into its product approval pathway, it's just too early to buy this stock with conviction.

Mankind Pharma has launched a Rs 3,000 crore QIP to fund its acquisition of Bharat Serums and Vaccines. The company has seen strong profit growth and significant stock returns. Shares of Mankind ...

As you can see from the chart above the percentage of shares that are sold short for Tonix Pharmaceuticals has declined since its last report. This does not mean that the stock is going to rise in ...